Methods for treating diseases related to the wnt pathway
Patent
·
OSTI ID:1650782
The present invention relates to methods for treating a disease, in which the disease arises from dysregulation of the Wnt signaling pathway. In some instances, the disease can be treated by administering a Wnt pathway inhibitory compound. In other instances, the method optionally includes conducting a genome-wide screening to determine one or more genes resulting in a reduced disease state and then identifying the gene(s) as being involved in the Wnt signaling pathway.
- Research Organization:
- Sandia National Lab. (SNL-CA), Livermore, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC04-94AL85000
- Assignee:
- National Technology & Engineering Solutions of Sandia, LLC (Albuquerque, NM)
- Patent Number(s):
- 10,624,949
- Application Number:
- 15/204,804
- OSTI ID:
- 1650782
- Resource Relation:
- Patent File Date: 07/07/2016
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cross talk between RNA N6‐methyladenosine methyltransferase‐like 3 and miR‐186 regulates hepatoblastoma progression through Wnt/β‐catenin signalling pathway
The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/{beta}-catenin signaling pathway
MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway
Journal Article
·
Wed Jan 22 00:00:00 EST 2020
· Cell Proliferation
·
OSTI ID:1650782
+7 more
The low-density lipoprotein receptor-related protein 10 is a negative regulator of the canonical Wnt/{beta}-catenin signaling pathway
Journal Article
·
Fri Feb 19 00:00:00 EST 2010
· Biochemical and Biophysical Research Communications
·
OSTI ID:1650782
+8 more
MicroRNA-1297 inhibits prostate cancer cell proliferation and invasion by targeting the AEG-1/Wnt signaling pathway
Journal Article
·
Fri Nov 11 00:00:00 EST 2016
· Biochemical and Biophysical Research Communications
·
OSTI ID:1650782
+3 more